Skip to content

HIV drug resistance becoming more common in Zambian infants

HIV drug resistance testing not a priority for resource-limited settings, trial finds

A quarter of people with second-line ART treatment failure in Kenya have exhausted current treatment options

Experimental STI prophylaxis in PrEP users produces big drops in syphilis and chlamydia infections but not in gonorrhoea

Jean-Michel Molina at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Treatment-as-prevention study sees substantial levels of transmitted drug resistance in participants, but no impact on treatment

Anne Derache at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Virologic failure detected in a quarter of ART-treated children in Tanzania

High prevalence of resistance to zidovudine among people in sub-Saharan Africa experiencing virological failure with tenofovir-containing ART

Rings, films or inserts? Researchers need to develop prevention products that make sense in women’s lives

Sharon Hillier presenting at HIVR4P. Image credit: http://hivr4p.org

Second case report of PrEP failure due to drug-resistant virus

Howard Grossman presenting at HIVR4P. Photo by Roger Pebody / aidsmap.com